ARMISTICE CAPITAL, LLC

Q1 2022 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
3/31/2022
Date filed
5/16/2022
Form type
13F-HR
Num holdings
141
Total value ($000)
$5,171,408
Net value change ($000)
-939,073 (-15.4%)
New positions
43
Sold out positions
60
Turnover %
52.9%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q4 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
HD 104,735 NEW
PTCT 76,745 210.1%
TGT 68,271 NEW
VTRS 63,104 NEW
NBIX 60,938 NEW
FIVE 57,290 NEW
Ortho Clinical Diagnostics Holdings plc 38,583 164.6%
ADBE 36,450 NEW
TOST 28,771 NEW
BUD 26,284 81.0%
Top Reduces (Value $000, Stocks/ETFs)
ASO -66,293 -100.0%
ULTA -62,114 -100.0%
IOVA -57,270 -100.0%
TJX -52,924 -100.0%
CROX -50,799 -100.0%
HAE -46,251 -100.0%
PARAV -45,994 -100.0%
VRTX -45,576 -42.5%
KO -44,763 -100.0%
QUIDEL CORP /DE/ -44,277 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,658,692 (32.1% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None